<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Immunohistochemical analysis of hippocampus and cortex region showed significantly decreased the BDNF expression in disease control animals (
 <xref ref-type="fig" rid="F11" class="xref">Figures 11b</xref>, 
 <xref ref-type="fig" rid="F12" class="xref">12b</xref>) as compared to normal control animals (
 <xref ref-type="fig" rid="F11" class="xref">Figures 11a</xref>, 
 <xref ref-type="fig" rid="F12" class="xref">12a</xref>). Optical density (OD) of disease control group was significantly lower as compared with that of normal control animals (
 <xref ref-type="fig" rid="F11" class="xref">Figures 11f</xref>, 
 <xref ref-type="fig" rid="F12" class="xref">12f</xref>). Treatment with cardamom oil at a dose of 100 mg/kg (
 <xref ref-type="fig" rid="F11" class="xref">Figures 11d</xref>, 
 <xref ref-type="fig" rid="F12" class="xref">12d</xref>) did not increase the expression of BDNF in hippocampus and cortex to normal. However, treatment with cardamom oil at a dose of 200 mg/kg (
 <xref ref-type="fig" rid="F11" class="xref">Figures 11e</xref>, 
 <xref ref-type="fig" rid="F12" class="xref">12e</xref>) showed the increase in BDNF expression in hippocampus and cortex when compared with disease control animals. The results at a dose of 200 mg/kg of cardamom oil are comparable as that of donepezil hydrochloride treated group (
 <xref ref-type="fig" rid="F11" class="xref">Figures 11c</xref>, 
 <xref ref-type="fig" rid="F12" class="xref">12c</xref>).
</p>
